Asthma medications
ATL/TV1102 (injection)has completed a Phase IIa trial as a potential treatment of multiplesclerosis. ATL1103 is a second-generation antisense drug designed to lowerblood IGF-I levels and is entering pre-clinical development as a potentialtreatment for acromegaly and vision disorders. ATL/TV1102 (inhaled) is atthe pre-clinical research stage as a potential treatment for asthma.ATL1101 is a second-generation antisense drug at the pre-clinical researchstage being investigated as a potential treatment for prostate cancer.ATL/TV1102 has been licensed to Teva Pharmaceutical Industries Ltd.
Website: www.antisense.com.au
Contact InformationUS Investors:Andrea CostaGrayling Global(646) 284-9461acostahfgcg.comCompany:Mark DiamondManaging Director+61 3 9827 8999
Accountability for patient safety was weak, effectively masking an unacceptably high level of incidents behind data gaps and inadequate reporting .
And the Victorians are supposed to be at the forefront of health reform.
The Business Council refers to this as the health system's lack of an evaluation culture , in part reflecting the dominant interests of providers. Australia stands out for its paucity of clear performance data by hospital or doctor. An estimated 20 per cent to 30 per cent of treatments are not based on the latest research evidence.
This disregard for patient interest does not bode well for the system's capacity to change from being designed institutionally, financially and culturally around specialised, episodic and acute care to preventing and managing mental illness, asthma, heart disease and cancer. Poor management of diabetes led to an estimated 200,000 preventable hospital admissions in 2004-05.
The role of lifestyle behaviour in today's chronic diseases throws greater responsibility on to individuals for managing their health
Blog Archives:
Toddler polo shirt
Cabinet catches
Glass tile wholesale
Buy mopeds
Asthma prognosis
Asthma resources
Laurey cabinet pulls
Asthma treatment protocol
Asthma pregnancy
Discount moped

<< Home